Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

135.11
Delayed Data
As of Feb 16
 +1.76 / +1.32%
Today’s Change
13.09
Today|||52-Week Range
154.75
+47.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
AssetsCash19.1M8.2M34.8M13.0M
 
 
 
 
 
Short Term Investment Cash10.8M-10.9M26.6M-21.8M
 
 
 
 
 
Cash & Short Term Investments40.5M40.1M67.2M62.1M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.000.00--
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets708.0K225.0K781.0K583.0K
 
 
 
 
 
Current Assets41.2M40.4M67.9M62.7M
 
 
 
 
 
 
Total AssetsOther Assets0.000.000.000.00--
Total Assets41.2M40.4M68.1M62.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable762.0K2.8M1.3M1.4M
 
 
 
 
 
Accrued Expenses4.0M3.1M5.2M7.1M
 
 
 
 
 
Other Current Liabilities4.0M3.1M5.2M7.1M
 
 
 
 
 
Other Liabilities4.8M5.9M6.4M8.5M
 
 
 
 
 
 
Total LiabilitiesTotal Liabilities4.8M5.9M6.4M8.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity36.4M34.5M61.6M54.3M
 
 
 
 
 
Total Shareholder Equity36.4M34.5M61.6M54.3M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding12.0M12.2M12.5M12.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.